The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Seung-Ho | - |
dc.contributor.author | Bahk, Won-Myong | - |
dc.contributor.author | Woo, Young Sup | - |
dc.contributor.author | Seo, Jeong Seok | - |
dc.contributor.author | Park, Young-Min | - |
dc.contributor.author | Kim, Won | - |
dc.contributor.author | Jeong, Jong-Hyun | - |
dc.contributor.author | Shim, Se-Hoon | - |
dc.contributor.author | Lee, Jung Goo | - |
dc.contributor.author | Jon, Duk-In | - |
dc.contributor.author | Min, Kyung Joon | - |
dc.date.accessioned | 2023-04-26T02:40:35Z | - |
dc.date.available | 2023-04-26T02:40:35Z | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22365 | - |
dc.description.abstract | Background. The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) is an expert consensus guideline for depressive disorder created in 2002, and since then, four revisions (2006, 2012, 2017, 2021) have been published. In this study, changes in the content of the KMAP-DD survey and recommendations for each period were examined. Methods. The development process of the KMAP-DD was composed of two stages. First, opinions from experts with abundant clinical experience were gathered through surveys. Next, a final guideline was prepared through discussion within the working committee regarding the suitability of the results with reference to recent clinical studies or other guidelines. Results. In mild depressive symptoms, antidepressant (AD) monotherapy was preferred, but when severe depression or when psychotic features were present, a combination of AD and atypical antipsychotics (AD + AAP) was preferred. AD monotherapy was preferred in most clinical subtypes. AD monotherapy was preferred for mild depressive symptoms, and AD + AAP was preferred for severe depression and depression with psychotic features in children, adolescents, and the elderly. Conclusions. This study identified the changes in the KMAP-DD treatment strategies and drug preferences in each period over the past 20 years. This work is expected to aid clinicians in establishing effective treatment strategies. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/jcm12031146 | - |
dc.identifier.scopusid | 2-s2.0-85147882072 | - |
dc.identifier.wosid | 000933750100001 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.12, no.3 | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 12 | - |
dc.citation.number | 3 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | CLINICAL GUIDELINES | - |
dc.subject.keywordPlus | MAJOR DEPRESSION | - |
dc.subject.keywordPlus | ATYPICAL ANTIPSYCHOTICS | - |
dc.subject.keywordPlus | PSYCHOTIC DEPRESSION | - |
dc.subject.keywordPlus | CANADIAN NETWORK | - |
dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | LATE-LIFE | - |
dc.subject.keywordPlus | PLACEBO | - |
dc.subject.keywordPlus | ANTIDEPRESSANT | - |
dc.subject.keywordAuthor | KAMP-DD | - |
dc.subject.keywordAuthor | depressive disorder | - |
dc.subject.keywordAuthor | expert consensus | - |
dc.subject.keywordAuthor | treatment strategy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.